Aclarion(NASDAQ) ACONW

Market CapN/A

Since IPO (2022)-97%

5 YearN/A

1 Year-25%

1 Month-15%

$0.03

+20%

+0.00Today

Aclarion last closing stock price
Metric	Price	Date
Last close	USD 0.02	2026-07-24

Aclarion stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+1.82%	USD 0.02	2026-07-17
1 month	-15.15%	USD 0.03	2026-06-24
3 month	-43.86%	USD 0.04	2026-04-24
Year to date	-40.9%	USD 0.04	2025-12-31
1 year	-24.83%	USD 0.03	2025-07-24
3 year	-72%	USD 0.08	2023-07-25
Since inception	-96.94%	USD 0.73	2022-04-22

Aclarion Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$77.88K

Net Income (TTM)

-$8.05M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.03

Volume

175,254

Open

$0.02

Price

$0.03

Volume

175,254

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.02 - $0.23

Estimated Earnings Date

Aug 28, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.03

Volume

175,254

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.02 - $0.23

Estimated Earnings Date

Aug 28, 2026

ACONW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aclarion

Aclarion, Inc. is a healthcare technology firm specializing in software development for magnetic resonance spectroscopy (MRS) within the U.S. market. The company’s flagship product is the NOCISCAN-LS Post-Processor suite, which includes tools for quantifying degenerative pain biomarkers and supporting clinical decision-making.

Products and Services

NOCISCAN-LS Post-Processor suite for MRS data analysis
NOCICALC-LS for quantifying degenerative pain biomarkers
NOCIGRAM-LS, a clinical decision support tool

Growth Outlook

Healthcare technology sector projected to grow significantly in the coming years
Increased demand for advanced diagnostic tools in pain management
Strategic partnerships may enhance market reach and product offerings

Financial Highlights

Recent quarterly revenue of $21,140, reflecting a growth trend
Cash and cash equivalents increased to $19,004,976 in Q1 2026
Current ratio of 19.65 indicates strong liquidity position

Aclarion, Inc. has positioned itself in a growing healthcare technology market, focusing on innovative solutions for pain management through advanced MRS analysis. The company’s flagship products are designed to enhance clinical decision-making and improve patient outcomes. Recent financial data indicates a positive trajectory, with increasing revenue and a robust liquidity position, suggesting potential for future growth. The healthcare sector's expansion and the rising need for sophisticated diagnostic tools further support Aclarion's strategic direction.

AI Generated • Jul 6, 2026

Industry

Health Care Technology

Sector

Health Care

Headquarters

Broomfield, CA 80020, US

ACONW Financials

Key Financial Metrics (TTM)

Gross Margin

-58.86%

Operating Margin

-10975.10%

Net Income Margin

-10336.12%

Return on Equity

-54.41%

Return on Capital

-54.95%

Return on Assets

-39.00%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

175.25K

Avg. Volume

22.58K

Financials (TTM)

Gross Profit

-$45.84K

Operating Income

-$8.55M

EBITDA

-$7.82M

Operating Cash Flow

-$7.30M

Capital Expenditure

-$49.25K

Free Cash Flow

-$7.34M

Cash & ST Invst.

$19.00M

Total Debt

$0.00

Aclarion Performance Analysis

Aclarion sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	1.7%
Q3	2025-09-30	-2.0%
Q4	2025-12-31	-2.4%
Q1	2026-03-31	14.4%

Aclarion sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	70.5%
Q3	2025-09-30	-6.6%
Q4	2025-12-31	24.6%
Q1	2026-03-31	39.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$21.14K

+11.3%

Gross Profit

-$57.16K

-1173.6%

Gross Margin

-2.70%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$2.85M

-40.1%

EBITDA

-$2.79M

-40.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$19.00M

+28.8%

Total Debt

$0.00

N/A

Accounts Receivable

$40.58K

+111.7%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-39.00%

N/A

Return on Invested Capital

-43.49%

N/A

Free Cash Flow

-$2.64M

-2.0%

Operating Cash Flow

-$2.64M

-5.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MDXLMedixall Group, Inc.

MDXLMedixall Group, Inc.$0.01+0.00%

ORHBORHub, Inc.

ORHBORHub, Inc.$0.00+0.00%

OLMMOneLife Technologies Corp.

OLMMOneLife Technologies Corp.$0.00+0.00%

APYIAspyra Inc.

APYIAspyra Inc.$0.00+0.00%

ICCTiCoreConnect Inc.

ICCTiCoreConnect Inc.$0.00+0.00%

NHELNatural Health Farm Holdings Inc.

NHELNatural Health Farm Holdings Inc.$0.00+0.00%

FDBHFounders Bay Holdings

FDBHFounders Bay Holdings$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.25+0.10%

NOKNokia

NOKNokia$9.28+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.95+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.24-0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$63.40-0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.88+0.03%

ONDSOndas

ONDSOndas$8.02+0.03%

Questions About ACONW

What is the current price of Aclarion?

Aclarion is trading at $0.02 per share.

What is the 52-week range for Aclarion?

Over the past 52 weeks, Aclarion has traded between $0.02 and $0.23.

How much debt does Aclarion have?

Aclarion total debt is unavailable.

How much cash does Aclarion have on hand?

Aclarion does not have cash on hand data available.

What is Aclarion’s dividend yield?

Aclarion does not currently have a dividend yield.

Aclarion(NASDAQ) ACONW

Aclarion Financials at a Glance

ACONW News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Aclarion

ACONW Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Aclarion Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ACONW

What is the current price of Aclarion?

What is the 52-week range for Aclarion?

How much debt does Aclarion have?

How much cash does Aclarion have on hand?

What is Aclarion’s dividend yield?

Premium Investing Services